|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0008976,
umls-concept:C0013072,
umls-concept:C0018034,
umls-concept:C0024501,
umls-concept:C0030705,
umls-concept:C0073917,
umls-concept:C0087111,
umls-concept:C0178602,
umls-concept:C0242708,
umls-concept:C0442796,
umls-concept:C1696465,
umls-concept:C2587213
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1994-5-9
|
|
pubmed:abstractText |
To examine the efficacy of the addition of small doses of additional disease modifying antirheumatic drugs (DMARD) to ongoing DMARD treatment [additive DMARD therapy (ADT)].
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
44-50
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8151586-Aged,
pubmed-meshheading:8151586-Anti-Inflammatory Agents,
pubmed-meshheading:8151586-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:8151586-Arthritis, Rheumatoid,
pubmed-meshheading:8151586-Child, Preschool,
pubmed-meshheading:8151586-Cysteine,
pubmed-meshheading:8151586-Double-Blind Method,
pubmed-meshheading:8151586-Drug Combinations,
pubmed-meshheading:8151586-Female,
pubmed-meshheading:8151586-Gold Sodium Thiomalate,
pubmed-meshheading:8151586-Humans,
pubmed-meshheading:8151586-Life Tables,
pubmed-meshheading:8151586-Male,
pubmed-meshheading:8151586-Middle Aged,
pubmed-meshheading:8151586-Placebos,
pubmed-meshheading:8151586-Prospective Studies,
pubmed-meshheading:8151586-Time Factors,
pubmed-meshheading:8151586-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate.
|
|
pubmed:affiliation |
Department of Clinical Immunology, Kyushu University, Beppu, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
